The Efficacy and Safety of PRO-Kinetic Metal Alloy Stent in Hospitalized Patients with Acute ST-Elevation Myocardial Infarction (The PROMETHEUS Study)
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lim, Sang-Yup | - |
dc.contributor.author | Park, Hyun-Woong | - |
dc.contributor.author | Chung, Woo-Young | - |
dc.contributor.author | Kim, Song-Yee | - |
dc.contributor.author | Kim, Ki-Seok | - |
dc.contributor.author | Bae, Jang-Whan | - |
dc.contributor.author | Youn, Tae-Jin | - |
dc.date.accessioned | 2021-09-06T18:59:54Z | - |
dc.date.available | 2021-09-06T18:59:54Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2012-06 | - |
dc.identifier.issn | 1042-3931 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/108204 | - |
dc.description.abstract | Background. We evaluated the clinical and angiographic outcomes of silicon carbide-coated cobalt chromium PRO-Kinetic bare-metal stent in patients with acute ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous coronary intervention (PCI). Methods. Patients with acute STEMI (2.75-5.00 mm vessels; lesion length <= 30 mm by visual estimation) were treated with PRO-Kinetic stents at 5 centers in Korea. The primary endpoint was the rate of major adverse cardiac events (MACE), defined as all-cause death, new myocardial infarction, and target lesion revascularization (TLR) at 6-month follow-up. Follow-up angiography was recommended after the completion of the 6-month clinical follow-up. Results. A total of 64 patients (56.6 +/- 12.9 years old, 56 male) were enrolled in the study. Procedural success was achieved in 100% of the lesions. The mean stent size was 3.51 +/- 0.67 mm and the mean stent length was 20.3 +/- 4.4 mm. There was 1 case of in-hospital death due to cardiac tamponade. During the 6-month clinical follow-up, 4 patients (6.3%) received TLR. Therefore, the total rate of MACE was 7.8%. Angiographic follow-up data were available for 42 patients (65.6%) and the in-stent late lumen loss was 1.02 +/- 0.62 mm and in-segment late lumen loss was 0.99 +/- 0.64 mm. Binary restenosis occurred in 53% of reference vessel diameters (RVDs) <= 3.0 mm, 25% of RVDs between 3.0 and 3.5 mm, and 0% of RVDs >3.5 mm (P=.006). Conclusions. The use of the PRO-Kinetic stent seems to be safe and feasible in primary PCI for acute STEMI, and shows favorable clinical and angiographic outcomes in large (>3.0 mm) coronary arteries, but not in small arteries. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | H M P COMMUNICATIONS | - |
dc.subject | DRUG-ELUTING STENTS | - |
dc.subject | ACUTE CORONARY SYNDROMES | - |
dc.subject | BARE-METAL | - |
dc.subject | SILICON-CARBIDE | - |
dc.subject | FOLLOW-UP | - |
dc.subject | PACLITAXEL | - |
dc.subject | IMPLANTATION | - |
dc.subject | THROMBOSIS | - |
dc.subject | OUTCOMES | - |
dc.subject | RESTENOSIS | - |
dc.title | The Efficacy and Safety of PRO-Kinetic Metal Alloy Stent in Hospitalized Patients with Acute ST-Elevation Myocardial Infarction (The PROMETHEUS Study) | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lim, Sang-Yup | - |
dc.identifier.wosid | 000304755200012 | - |
dc.identifier.bibliographicCitation | JOURNAL OF INVASIVE CARDIOLOGY, v.24, no.6, pp.270 - 273 | - |
dc.relation.isPartOf | JOURNAL OF INVASIVE CARDIOLOGY | - |
dc.citation.title | JOURNAL OF INVASIVE CARDIOLOGY | - |
dc.citation.volume | 24 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 270 | - |
dc.citation.endPage | 273 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Cardiac & Cardiovascular Systems | - |
dc.subject.keywordPlus | DRUG-ELUTING STENTS | - |
dc.subject.keywordPlus | ACUTE CORONARY SYNDROMES | - |
dc.subject.keywordPlus | BARE-METAL | - |
dc.subject.keywordPlus | SILICON-CARBIDE | - |
dc.subject.keywordPlus | FOLLOW-UP | - |
dc.subject.keywordPlus | PACLITAXEL | - |
dc.subject.keywordPlus | IMPLANTATION | - |
dc.subject.keywordPlus | THROMBOSIS | - |
dc.subject.keywordPlus | OUTCOMES | - |
dc.subject.keywordPlus | RESTENOSIS | - |
dc.subject.keywordAuthor | bare-metal stent | - |
dc.subject.keywordAuthor | acute myocardial infarction | - |
dc.subject.keywordAuthor | restenosis | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.